National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

darbepoetin alfa
A recombinant analog of the endogenous cytokine erythropoietin, an erythropoiesis-stimulating protein. Due to the addition of two carbohydrate chains, darbepoetin alfa exhibits a three-fold greater half-life than does erythropoietin. Similar to erythropoietin, darbopoietin alfa binds to and activates epoetin receptors, thereby inducing the differentiation and maturation of erythrocyte progenitors, stimulating endothelial cell proliferation, and stimulating B-cell proliferation and immunoglobulin production. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:Novel Erythropoiesis Stimulating Protein
US brand name:Aranesp
Foreign brand name:Nespo
Abbreviation:NESP
Code name:KRN321



Previous:danazol, daniquidone, Danocrine, daptomycin, Daraprim
Next:darinaparsin, dasatinib, daunorubicin hydrochloride, DaunoXome, DC-OVA vaccine

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov